chr19-55161315-G-C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_001256715.2(DNAAF3):c.767C>G(p.Ala256Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000259 in 1,610,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A256V) has been classified as Uncertain significance.
Frequency
Consequence
NM_001256715.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAAF3 | NM_001256715.2 | c.767C>G | p.Ala256Gly | missense_variant | Exon 7 of 12 | ENST00000524407.7 | NP_001243644.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAAF3 | ENST00000524407.7 | c.767C>G | p.Ala256Gly | missense_variant | Exon 7 of 12 | 1 | NM_001256715.2 | ENSP00000432046.3 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 151808Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.000161 AC: 39AN: 242054 AF XY: 0.000159 show subpopulations
GnomAD4 exome AF: 0.000266 AC: 388AN: 1458698Hom.: 0 Cov.: 39 AF XY: 0.000250 AC XY: 181AN XY: 725428 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000191 AC: 29AN: 151926Hom.: 0 Cov.: 30 AF XY: 0.000148 AC XY: 11AN XY: 74258 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:3
The c.908C>G (p.A303G) alteration is located in exon 7 (coding exon 7) of the DNAAF3 gene. This alteration results from a C to G substitution at nucleotide position 908, causing the alanine (A) at amino acid position 303 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 324 of the DNAAF3 protein (p.Ala324Gly). This variant is present in population databases (rs201937522, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DNAAF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 454627). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
The p.A324G variant (also known as c.971C>G), located in coding exon 7 of the DNAAF3 gene, results from a C to G substitution at nucleotide position 971. The alanine at codon 324 is replaced by glycine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at